Article Details

Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to ...

Retrieved on: 2021-07-20 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to .... View article details on HISWAI: https://www.biospace.com/article/releases/relmada-therapeutics-announces-the-acquisition-of-development-and-commercial-rights-to-novel-psilocybin-and-derivates-program-from-arbormentis-llc/

Excerpt

(Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced the acquisition of ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up